WASHINGTON—Subcommittee on Health Care and Financial Services Chairwoman Lisa McClain (R-Mich.) will hold a hearing titled “FDA Oversight Part I: The Infant Formula Shortage” to investigate the U.S. Food and Drug Administration’s (FDA) response to the infant formula crisis, including the FDA’s failure to heed watchdog warnings about a bacteria outbreak in a formula production facility in Michigan and the Biden Administration’s failure to respond to the nationwide shortage.
“Now more than a year after this crisis began, the Biden Administration continues to fail parents and caretakers across the country as they are still struggling to find infant formula to feed their babies, with no end in sight. American families deserve answers as to why the Food and Drug Administration and the Biden Administration ignored watchdog warnings for months, ultimately making the crisis worse. We are going to conduct oversight of the FDA and be sure we take steps to prevent another avoidable crisis like this from happening again,” said Subcommittee Chairwoman Lisa McClain.
WHAT: Hearing titled “FDA Oversight Part I: The Infant Formula Shortage”
DATE: March 28, 2023
TIME: 10:00 AM EST
LOCATION: 2247 Rayburn House Office Building
WITNESSES: Frank Yiannas, Former Deputy Commissioner, Office of Food Policy & Response, U.S. Food and Drug Administration
The hearing will be open to the public and press and will be livestreamed online at https://oversight.house.gov/.